enGene Statistics
Share Statistics
enGene has 51.11M
shares outstanding. The number of shares has increased by 15.58%
in one year.
| 51.11M |
| 15.58% |
| 0.25% |
| 80.31% |
| 21.87M |
| 668 |
| 0.68% |
Short Selling Information
The latest short interest is 23.36K, so 0.05% of the outstanding
shares have been sold short.
| 23.36K |
| 0.05% |
| 0.06% |
| 1 |
Valuation Ratios
The PE ratio is 7.16 and the forward
PE ratio is -1.67.
enGene's PEG ratio is
-0.06.
| 7.16 |
| -1.67 |
| 0 |
| 39.6 |
| 1.45 |
| -8.03 |
| -0.06 |
Financial Ratio History Enterprise Valuation
enGene has an Enterprise Value (EV) of 247.06M.
| 0 |
| 3.97 |
| -5.12 |
| -5.02 |
Financial Position
The company has a current ratio of 16.87,
with a Debt / Equity ratio of 0.09.
| 16.87 |
| 16.87 |
| 0.09 |
| 0.4 |
| -0.51 |
| 22.26 |
Financial Efficiency
Return on Equity is 20.23% and Return on Invested Capital is 20.94%.
| 20.23% |
| 17.72% |
| 20.94% |
| n/a |
| $984.68K |
| 56 |
| 0 |
| n/a |
Taxes
| -19K |
| -0.03% |
Stock Price Statistics
The stock price has increased by -43.79% in the
last 52 weeks. The beta is -0.41, so enGene's
price volatility has been lower than the market average.
| -0.41 |
| -43.79% |
| 3.61 |
| 5.51 |
| 49.74 |
| 98,141 |
Income Statement
| n/a |
| n/a |
| 62.3M |
| 55.14M |
| 62.3M |
| 57.96M |
| 1.24 |
Full Income Statement Balance Sheet
The company has 173M in cash and 25.02M in
debt, giving a net cash position of 147.98M.
| 173M |
| 25.02M |
| 147.98M |
| -254.73M |
| 266.65M |
| 209.97M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -48.28M
and capital expenditures -925K, giving a free cash flow of -49.21M.
| -48.28M |
| -925K |
| -49.21M |
| -1.1 |
Full Cash Flow Statement Margins
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |